158 related articles for article (PubMed ID: 23422727)
1. Block/homo polyplex micelle-based GM-CSF gene therapy via intraperitoneal administration elicits antitumor immunity against peritoneal dissemination and exhibits safety potentials in mice and cynomolgus monkeys.
Ohgidani M; Furugaki K; Shinkai K; Kunisawa Y; Itaka K; Kataoka K; Nakano K
J Control Release; 2013 May; 167(3):238-47. PubMed ID: 23422727
[TBL] [Abstract][Full Text] [Related]
2. Effective transgene expression without toxicity by intraperitoneal administration of PEG-detachable polyplex micelles in mice with peritoneal dissemination.
Kumagai M; Shimoda S; Wakabayashi R; Kunisawa Y; Ishii T; Osada K; Itaka K; Nishiyama N; Kataoka K; Nakano K
J Control Release; 2012 Jun; 160(3):542-51. PubMed ID: 22484197
[TBL] [Abstract][Full Text] [Related]
3. Polyplex micelle installing intracellular self-processing functionalities without free catiomers for safe and efficient systemic gene therapy through tumor vasculature targeting.
Chen Q; Osada K; Ge Z; Uchida S; Tockary TA; Dirisala A; Matsui A; Toh K; Takeda KM; Liu X; Nomoto T; Ishii T; Oba M; Matsumoto Y; Kataoka K
Biomaterials; 2017 Jan; 113():253-265. PubMed ID: 27835820
[TBL] [Abstract][Full Text] [Related]
4. Polyplex micelles prepared from ω-cholesteryl PEG-polycation block copolymers for systemic gene delivery.
Oba M; Miyata K; Osada K; Christie RJ; Sanjoh M; Li W; Fukushima S; Ishii T; Kano MR; Nishiyama N; Koyama H; Kataoka K
Biomaterials; 2011 Jan; 32(2):652-63. PubMed ID: 20932567
[TBL] [Abstract][Full Text] [Related]
5. Combination of chondroitin sulfate and polyplex micelles from Poly(ethylene glycol)-poly{N'-[N-(2-aminoethyl)-2-aminoethyl]aspartamide} block copolymer for prolonged in vivo gene transfection with reduced toxicity.
Uchida S; Itaka K; Chen Q; Osada K; Miyata K; Ishii T; Harada-Shiba M; Kataoka K
J Control Release; 2011 Oct; 155(2):296-302. PubMed ID: 21571018
[TBL] [Abstract][Full Text] [Related]
6. Homo-catiomer integration into PEGylated polyplex micelle from block-catiomer for systemic anti-angiogenic gene therapy for fibrotic pancreatic tumors.
Chen Q; Osada K; Ishii T; Oba M; Uchida S; Tockary TA; Endo T; Ge Z; Kinoh H; Kano MR; Itaka K; Kataoka K
Biomaterials; 2012 Jun; 33(18):4722-30. PubMed ID: 22444644
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of a subcutaneously administered block/homo-mixed polyplex micelle as a carrier for DNA vaccination in a mouse tumor model.
Cui L; Osada K; Imaizumi A; Kataoka K; Nakano K
J Control Release; 2015 May; 206():220-31. PubMed ID: 25819159
[TBL] [Abstract][Full Text] [Related]
8. Ternary polyplex micelles with PEG shells and intermediate barrier to complexed DNA cores for efficient systemic gene delivery.
Li J; Chen Q; Zha Z; Li H; Toh K; Dirisala A; Matsumoto Y; Osada K; Kataoka K; Ge Z
J Control Release; 2015 Jul; 209():77-87. PubMed ID: 25912408
[TBL] [Abstract][Full Text] [Related]
9. PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors.
Takae S; Miyata K; Oba M; Ishii T; Nishiyama N; Itaka K; Yamasaki Y; Koyama H; Kataoka K
J Am Chem Soc; 2008 May; 130(18):6001-9. PubMed ID: 18396871
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1.
Oba M; Vachutinsky Y; Miyata K; Kano MR; Ikeda S; Nishiyama N; Itaka K; Miyazono K; Koyama H; Kataoka K
Mol Pharm; 2010 Apr; 7(2):501-9. PubMed ID: 20178335
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer using micellar nanovectors inhibits corneal neovascularization in vivo.
Iriyama A; Usui T; Yanagi Y; Amano S; Oba M; Miyata K; Nishiyama N; Kataoka K
Cornea; 2011 Dec; 30(12):1423-7. PubMed ID: 21975440
[TBL] [Abstract][Full Text] [Related]
12. Polyplex micelles from triblock copolymers composed of tandemly aligned segments with biocompatible, endosomal escaping, and DNA-condensing functions for systemic gene delivery to pancreatic tumor tissue.
Miyata K; Oba M; Kano MR; Fukushima S; Vachutinsky Y; Han M; Koyama H; Miyazono K; Nishiyama N; Kataoka K
Pharm Res; 2008 Dec; 25(12):2924-36. PubMed ID: 18781378
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal administration of a tumor-associated antigen SART3, CD40L, and GM-CSF gene-loaded polyplex micelle elicits a vaccine effect in mouse tumor models.
Furugaki K; Cui L; Kunisawa Y; Osada K; Shinkai K; Tanaka M; Kataoka K; Nakano K
PLoS One; 2014; 9(7):e101854. PubMed ID: 25013909
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for nucleus pulposus regeneration by heme oxygenase-1 plasmid DNA carried by mixed polyplex micelles with thermo-responsive heterogeneous coronas.
Feng G; Chen H; Li J; Huang Q; Gupte MJ; Liu H; Song Y; Ge Z
Biomaterials; 2015 Jun; 52():1-13. PubMed ID: 25818409
[TBL] [Abstract][Full Text] [Related]
15. Biocompatible micellar nanovectors achieve efficient gene transfer to vascular lesions without cytotoxicity and thrombus formation.
Akagi D; Oba M; Koyama H; Nishiyama N; Fukushima S; Miyata T; Nagawa H; Kataoka K
Gene Ther; 2007 Jul; 14(13):1029-38. PubMed ID: 17460721
[TBL] [Abstract][Full Text] [Related]
16. pH-responsive three-layered PEGylated polyplex micelle based on a lactosylated ABC triblock copolymer as a targetable and endosome-disruptive nonviral gene vector.
Oishi M; Kataoka K; Nagasaki Y
Bioconjug Chem; 2006; 17(3):677-88. PubMed ID: 16704205
[TBL] [Abstract][Full Text] [Related]
17. Impact of polyplex micelles installed with cyclic RGD peptide as ligand on gene delivery to vascular lesions.
Kagaya H; Oba M; Miura Y; Koyama H; Ishii T; Shimada T; Takato T; Kataoka K; Miyata T
Gene Ther; 2012 Jan; 19(1):61-9. PubMed ID: 21654819
[TBL] [Abstract][Full Text] [Related]
18. PEG-based block catiomers possessing DNA anchoring and endosomal escaping functions to form polyplex micelles with improved stability and high transfection efficacy.
Miyata K; Fukushima S; Nishiyama N; Yamasaki Y; Kataoka K
J Control Release; 2007 Oct; 122(3):252-60. PubMed ID: 17643543
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic gene therapy of experimental pancreatic tumor by sFlt-1 plasmid DNA carried by RGD-modified crosslinked polyplex micelles.
Vachutinsky Y; Oba M; Miyata K; Hiki S; Kano MR; Nishiyama N; Koyama H; Miyazono K; Kataoka K
J Control Release; 2011 Jan; 149(1):51-7. PubMed ID: 20138936
[TBL] [Abstract][Full Text] [Related]
20. PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.
Kim HJ; Oba M; Pittella F; Nomoto T; Cabral H; Matsumoto Y; Miyata K; Nishiyama N; Kataoka K
J Drug Target; 2012 Jan; 20(1):33-42. PubMed ID: 22066783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
